PE20090106A1 - Derivados de eritromicina como agentes antibacterianos - Google Patents
Derivados de eritromicina como agentes antibacterianosInfo
- Publication number
- PE20090106A1 PE20090106A1 PE2008000454A PE2008000454A PE20090106A1 PE 20090106 A1 PE20090106 A1 PE 20090106A1 PE 2008000454 A PE2008000454 A PE 2008000454A PE 2008000454 A PE2008000454 A PE 2008000454A PE 20090106 A1 PE20090106 A1 PE 20090106A1
- Authority
- PE
- Peru
- Prior art keywords
- methyl
- hydroxy
- naphthyridin
- azethydin
- descladinosyl
- Prior art date
Links
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 CYCLOBUTYL Chemical class 0.000 abstract 1
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- XIPUIGPNIDKXJU-UHFFFAOYSA-N [CH]1CC1 Chemical class [CH]1CC1 XIPUIGPNIDKXJU-UHFFFAOYSA-N 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000842 anti-protozoal effect Effects 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
REFERIDA A UN DERIVADO DE ERITROMICINA DE FORMULA (I), DONDE R1 ES 3-HIDROXI-[1,5-NAFTIRIDIN-4-ILO, 3-HIDROXI-[1,6]-NAFTIRIDIN-4-ILO, 3-HIDROXI-[1,7]-NAFTIRIDIN-4-ILO, OPCIONALMENTE SUSTITUIDOS CON ALQUILO C1-C3, CICLOPROPILO Y CICLOBUTILO; R2 ES H, METILO, ETILO; X ES H O FLUOR. SON COMPUESTOS PREFERIDOS: FUMARATO DE 3-DESCLADINOSIL-11,12-DIDESOXI-6-O-METIL-3-OXO-12,11-(OXICARBONIL-(1-((3-HIDROXI-[1,5]-NAFTIRIDIN-4-IL)METIL)-AZETIDIN-3-IL)-IMINO)-ERITROMICINA A, FUMARATO DE 3-DESCLADINOSIL-11,12-DIDESOXI-6-O-METIL-3-OXO-12,11-(OXICARBONIL-(1-((3-HIDROXI-[1,6]-NAFTIRIDIN-4-IL)METIL)-AZETIDIN-3-IL)-IMINO)-ERITROMICINA A, FUMARATO DE 3-DESCLADINOSIL-11,12-DIDESOXI-6-O-METIL-3-OXO-12,11-(OXICARBONIL-(1-((3-HIDROXI-8-METIL-[1,5-NAFTIRIDIN-4-IL)METIL)-AZETIDIN-3-IL)-IMINO)-ERITROMICINA A, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS TIENEN ACTIVIDAD ANTIBACTERIANA Y ANTIPROTOZOARIA Y SON UTILES EN EL TRATAMIENTO DE INFECCIONES DEL TRACTO RESPIRATORIO, SINUSITIS, NEUMONIA DE ORIGEN COMUNITARIO, ENTRE OTROS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89447507P | 2007-03-13 | 2007-03-13 | |
| US2337008P | 2008-01-24 | 2008-01-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090106A1 true PE20090106A1 (es) | 2009-02-08 |
Family
ID=39760163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008000454A PE20090106A1 (es) | 2007-03-13 | 2008-03-11 | Derivados de eritromicina como agentes antibacterianos |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20080293646A1 (es) |
| EP (1) | EP2125851B1 (es) |
| JP (1) | JP4468487B1 (es) |
| KR (1) | KR20090110381A (es) |
| CN (1) | CN101631795A (es) |
| AP (1) | AP2009004985A0 (es) |
| AR (1) | AR065724A1 (es) |
| AT (1) | ATE471943T1 (es) |
| AU (1) | AU2008224633A1 (es) |
| BR (1) | BRPI0809002A2 (es) |
| CA (1) | CA2680527A1 (es) |
| CL (1) | CL2008000695A1 (es) |
| CR (1) | CR10998A (es) |
| CU (1) | CU20090155A7 (es) |
| DE (1) | DE602008001611D1 (es) |
| DO (1) | DOP2009000214A (es) |
| EA (1) | EA200901059A1 (es) |
| EC (1) | ECSP099627A (es) |
| IL (1) | IL200613A0 (es) |
| MA (1) | MA31252B1 (es) |
| MX (1) | MX2009009074A (es) |
| PA (1) | PA8772401A1 (es) |
| PE (1) | PE20090106A1 (es) |
| SV (1) | SV2009003368A (es) |
| TN (1) | TN2009000374A1 (es) |
| TW (1) | TW200848061A (es) |
| UY (1) | UY30957A1 (es) |
| WO (1) | WO2008110918A2 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014022106B1 (pt) * | 2012-03-06 | 2022-08-02 | Pfizer Inc | Derivados macrocíclicos, combinação, composição e usos na fabricação de um medicamento para o tratamento de doenças |
| CA3130061C (en) | 2013-04-04 | 2024-05-28 | President And Fellows Of Harvard College | Macrolides and methods of their preparation and use |
| WO2016057798A1 (en) | 2014-10-08 | 2016-04-14 | President And Fellows Of Harvard College | 14-membered ketolides and methods of their preparation and use |
| EP3273969A4 (en) | 2015-03-25 | 2018-11-21 | President and Fellows of Harvard College | Macrolides with modified desosamine sugars and uses thereof |
| CN105924451B (zh) * | 2016-04-27 | 2017-12-15 | 国家海洋局第三海洋研究所 | 具有抗茶叶致病真菌活性的大环内酯化合物及制备与用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2233493A1 (en) * | 2004-12-21 | 2010-09-29 | Pfizer Products Inc. | Macrolides |
-
2008
- 2008-03-04 AT AT08719365T patent/ATE471943T1/de not_active IP Right Cessation
- 2008-03-04 JP JP2009553232A patent/JP4468487B1/ja active Active
- 2008-03-04 CN CN200880008148A patent/CN101631795A/zh active Pending
- 2008-03-04 CU CU20090155A patent/CU20090155A7/es unknown
- 2008-03-04 MX MX2009009074A patent/MX2009009074A/es not_active Application Discontinuation
- 2008-03-04 BR BRPI0809002-5A2A patent/BRPI0809002A2/pt not_active IP Right Cessation
- 2008-03-04 AU AU2008224633A patent/AU2008224633A1/en not_active Abandoned
- 2008-03-04 KR KR1020097019014A patent/KR20090110381A/ko not_active Ceased
- 2008-03-04 EP EP08719365A patent/EP2125851B1/en active Active
- 2008-03-04 EA EA200901059A patent/EA200901059A1/ru unknown
- 2008-03-04 CA CA002680527A patent/CA2680527A1/en not_active Abandoned
- 2008-03-04 AP AP2009004985A patent/AP2009004985A0/xx unknown
- 2008-03-04 DE DE602008001611T patent/DE602008001611D1/de active Active
- 2008-03-04 WO PCT/IB2008/000715 patent/WO2008110918A2/en not_active Ceased
- 2008-03-07 CL CL200800695A patent/CL2008000695A1/es unknown
- 2008-03-11 PE PE2008000454A patent/PE20090106A1/es not_active Application Discontinuation
- 2008-03-12 UY UY30957A patent/UY30957A1/es not_active Application Discontinuation
- 2008-03-12 US US12/047,154 patent/US20080293646A1/en not_active Abandoned
- 2008-03-12 TW TW097108663A patent/TW200848061A/zh unknown
- 2008-03-13 AR ARP080101036A patent/AR065724A1/es unknown
- 2008-03-13 PA PA20088772401A patent/PA8772401A1/es unknown
-
2009
- 2009-08-26 CR CR10998A patent/CR10998A/es unknown
- 2009-08-27 IL IL200613A patent/IL200613A0/en unknown
- 2009-09-08 DO DO2009000214A patent/DOP2009000214A/es unknown
- 2009-09-11 TN TNP2009000374A patent/TN2009000374A1/fr unknown
- 2009-09-11 MA MA32219A patent/MA31252B1/fr unknown
- 2009-09-11 EC EC2009009627A patent/ECSP099627A/es unknown
- 2009-09-11 SV SV2009003368A patent/SV2009003368A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200848061A (en) | 2008-12-16 |
| WO2008110918A3 (en) | 2009-01-29 |
| EP2125851B1 (en) | 2010-06-23 |
| AU2008224633A1 (en) | 2008-09-18 |
| CR10998A (es) | 2009-09-11 |
| AR065724A1 (es) | 2009-06-24 |
| DE602008001611D1 (en) | 2010-08-05 |
| ECSP099627A (es) | 2009-10-30 |
| PA8772401A1 (es) | 2008-11-19 |
| UY30957A1 (es) | 2008-10-31 |
| EA200901059A1 (ru) | 2010-02-26 |
| CU20090155A7 (es) | 2011-04-26 |
| CN101631795A (zh) | 2010-01-20 |
| TN2009000374A1 (fr) | 2010-12-31 |
| ATE471943T1 (de) | 2010-07-15 |
| CA2680527A1 (en) | 2008-09-18 |
| IL200613A0 (en) | 2010-05-17 |
| JP2010521448A (ja) | 2010-06-24 |
| JP4468487B1 (ja) | 2010-05-26 |
| EP2125851A2 (en) | 2009-12-02 |
| SV2009003368A (es) | 2009-11-09 |
| MA31252B1 (fr) | 2010-03-01 |
| MX2009009074A (es) | 2009-09-28 |
| BRPI0809002A2 (pt) | 2014-11-11 |
| WO2008110918A2 (en) | 2008-09-18 |
| DOP2009000214A (es) | 2009-10-31 |
| AP2009004985A0 (en) | 2009-10-31 |
| CL2008000695A1 (es) | 2008-09-22 |
| US20080293646A1 (en) | 2008-11-27 |
| KR20090110381A (ko) | 2009-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090235A1 (es) | Compuestos heterociclicos nitrogenados antibacterianos y su preparacion | |
| ECSP088836A (es) | Derivados de purina para utilizarse como agonistas del receptor de adenosina a2a | |
| MX358311B (es) | Compuesto heterociclico que contiene nitrogeno o sal del mismo. | |
| DOP2012000011A (es) | Formulacion farmaceutica | |
| MX2012002179A (es) | Compuestos heterociclicos de oxima. | |
| CO6382125A2 (es) | Inhibidores de proteína quinasa | |
| MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
| CO6440512A2 (es) | Composiciòn farmacèutica que contiene derivado de quinolina | |
| NO20092542L (no) | Antibakterielle kinolin-derivater | |
| TN2012000125A1 (en) | Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors | |
| PE20120052A1 (es) | Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c][1,2]-oxaborol-1-ol | |
| PE20110392A1 (es) | Combinacion farmaceutica que comprende heterociclicos nitrogenados antibacterianos con otro antibacteriano | |
| PE20120648A1 (es) | Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1 | |
| PT2323972E (pt) | Compostos de tetraciclina substituídos com c7-flúor | |
| PE20090106A1 (es) | Derivados de eritromicina como agentes antibacterianos | |
| PE20110069A1 (es) | Compuestos de tetraciclina sustituidos | |
| NZ600912A (en) | Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection | |
| NZ596628A (en) | Ketolide compounds having antimicrobial activity | |
| IN2012DN02502A (es) | ||
| UA101305C2 (ru) | Антибактериальные производные хинолина | |
| MX2011013869A (es) | Agentes antihelminticos y su uso. | |
| MX2009006325A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
| AR071780A1 (es) | Derivados de carbamoilo de carbonilamino-pirazoles biciclicos como profarmacos | |
| UY32593A (es) | "compuestos sustituidos de 3-azetidin de 3-azetidin-1-il)(5-fenil-1,3,4-oxadiazol-2-il) metanona | |
| PE20140239A1 (es) | Derivados de 1,4-oxazepano |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |